Literature DB >> 24947514

Calcineurin-mediated YB-1 dephosphorylation regulates CCL5 expression during monocyte differentiation.

Christina Alidousty1, Thomas Rauen1, Lydia Hanssen1, Qiang Wang2, Setareh Alampour-Rajabi3, Peter R Mertens4, Jürgen Bernhagen3, Jürgen Floege1, Tammo Ostendorf1, Ute Raffetseder5.   

Abstract

Y-box (YB) protein-1 serves as a master regulator in gene transcription and mRNA translation. YB-1 itself is regulated at various levels, e.g. through post-translational modifications. In our previous work, we identified RANTES/CCL5 as a transcriptional target of YB-1. We previously demonstrated that YB-1 protein is transiently up-regulated during monocyte/macrophage differentiation evidenced in monocytic cells (THP-1 cells) that were differentiated using phorbol myristate acetate (PMA). Here we provide evidence that YB-1 phosphorylation, specifically at its serine residue 102 (Ser-102), increases early on in THP-1 cells following PMA treatment as well as in differentiated primary human monocytes. This process is mediated through the Akt signaling pathway. Ser-102-phosphorylated YB-1 displays stronger binding affinity and trans-activating capacity at the CCL5 gene promoter. Notably, Ser-102-phosphorylated YB-1 disappears at later stages of the monocyte/macrophage differentiation process. We demonstrate that serine-threonine phosphatase calcineurin (CN) dephosphorylates YB-1 preventing it from binding to and trans-activating the CCL5 promoter. Co-immunoprecipitation assays prove a direct YB-1/CN interaction. Furthermore, analyses in kidney tissues from mice that were treated with the CN inhibitor cyclosporine A revealed an in vivo effect of CN on the YB-1 phosphorylation status. We conclude that YB-1 phosphorylation at Ser-102 is an important prerequisite for CCL5 promoter activation during macrophage differentiation. Our findings point to a critical role of YB-1 in the resolution of inflammatory processes which may largely be due to CN-mediated dephosphorylation.
© 2014 by The American Society for Biochemistry and Molecular Biology, Inc.

Entities:  

Keywords:  CCL5; Calcineurin; Chemokine; Gene Expression; Gene Regulation; Monocyte Differentiation; Phosphatase; Y-box Protein-1

Mesh:

Substances:

Year:  2014        PMID: 24947514      PMCID: PMC4118104          DOI: 10.1074/jbc.M114.562991

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  39 in total

1.  AKAP79/150 anchoring of calcineurin controls neuronal L-type Ca2+ channel activity and nuclear signaling.

Authors:  Seth F Oliveria; Mark L Dell'Acqua; William A Sather
Journal:  Neuron       Date:  2007-07-19       Impact factor: 17.173

2.  YB-1 acts as a ligand for Notch-3 receptors and modulates receptor activation.

Authors:  Thomas Rauen; Ute Raffetseder; Björn C Frye; Sonja Djudjaj; Philipp J T Mühlenberg; Frank Eitner; Urban Lendahl; Jürgen Bernhagen; Steven Dooley; Peter R Mertens
Journal:  J Biol Chem       Date:  2009-07-29       Impact factor: 5.157

3.  Role of kinases and the phosphatase calcineurin in the nuclear shuttling of transcription factor NF-AT4.

Authors:  F Shibasaki; E R Price; D Milan; F McKeon
Journal:  Nature       Date:  1996-07-25       Impact factor: 49.962

4.  Two-site interaction of nuclear factor of activated T cells with activated calcineurin.

Authors:  F J Garcia-Cozar; H Okamura; J F Aramburu; K T Shaw; L Pelletier; R Showalter; E Villafranca; A Rao
Journal:  J Biol Chem       Date:  1998-09-11       Impact factor: 5.157

Review 5.  Transcription factors of the NFAT family: regulation and function.

Authors:  A Rao; C Luo; P G Hogan
Journal:  Annu Rev Immunol       Date:  1997       Impact factor: 28.527

6.  The transcriptional regulatory protein, YB-1, promotes single-stranded regions in the DRA promoter.

Authors:  G H MacDonald; Y Itoh-Lindstrom; J P Ting
Journal:  J Biol Chem       Date:  1995-02-24       Impact factor: 5.157

7.  Nucleolin and YB-1 are required for JNK-mediated interleukin-2 mRNA stabilization during T-cell activation.

Authors:  C Y Chen; R Gherzi; J S Andersen; G Gaietta; K Jürchott; H D Royer; M Mann; M Karin
Journal:  Genes Dev       Date:  2000-05-15       Impact factor: 11.361

8.  Alternative splicing regulation by interaction of phosphatase PP2Cgamma with nucleic acid-binding protein YB-1.

Authors:  Eric Allemand; Michelle L Hastings; Michael V Murray; Michael P Myers; Adrian R Krainer
Journal:  Nat Struct Mol Biol       Date:  2007-06-17       Impact factor: 15.369

9.  YB-1 is an early and central mediator of bacterial and sterile inflammation in vivo.

Authors:  Lydia Hanssen; Christina Alidousty; Sonja Djudjaj; Björn C Frye; Thomas Rauen; Peter Boor; Peter R Mertens; Claudia R van Roeyen; Frank Tacke; Felix Heymann; Andre P Tittel; Alexander Koch; Jürgen Floege; Tammo Ostendorf; Ute Raffetseder
Journal:  J Immunol       Date:  2013-07-19       Impact factor: 5.422

10.  YB-1 is a Transcription/Translation Factor that Orchestrates the Oncogenome by Hardwiring Signal Transduction to Gene Expression.

Authors:  Joyce Wu; Anna L Stratford; Arezoo Astanehe; Sandra E Dunn
Journal:  Transl Oncogenomics       Date:  2007-05-11
View more
  12 in total

1.  Alternatively activated macrophages in the pathogenesis of chronic kidney allograft injury.

Authors:  Yohei Ikezumi; Toshiaki Suzuki; Takeshi Yamada; Hiroya Hasegawa; Utako Kaneko; Masanori Hara; Toshio Yanagihara; David J Nikolic-Paterson; Akihiko Saitoh
Journal:  Pediatr Nephrol       Date:  2014-12-09       Impact factor: 3.714

2.  Differential control of interleukin-6 mRNA levels by cellular distribution of YB-1.

Authors:  Sujin Kang; Taeyun A Lee; Eun A Ra; Eunhye Lee; Hyun jin Choi; Sungwook Lee; Boyoun Park
Journal:  PLoS One       Date:  2014-11-14       Impact factor: 3.240

3.  YB-1 orchestrates onset and resolution of renal inflammation via IL10 gene regulation.

Authors:  Jialin Wang; Sonja Djudjaj; Lydia Gibbert; Vera Lennartz; Daniel M Breitkopf; Thomas Rauen; Daniela Hermert; Ina V Martin; Peter Boor; Gerald S Braun; Jürgen Floege; Tammo Ostendorf; Ute Raffetseder
Journal:  J Cell Mol Med       Date:  2017-06-30       Impact factor: 5.310

4.  Long Non-coding RNA Aerrie Controls DNA Damage Repair via YBX1 to Maintain Endothelial Cell Function.

Authors:  Tan Phát Pham; Diewertje I Bink; Laura Stanicek; Anke van Bergen; Esmee van Leeuwen; Yvonne Tran; Ljubica Matic; Ulf Hedin; Ilka Wittig; Stefanie Dimmeler; Reinier A Boon
Journal:  Front Cell Dev Biol       Date:  2021-01-11

5.  Differential Lyn-dependence of the SHIP1-deficient mast cell phenotype.

Authors:  Susana M Nunes de Miranda; Thomas Wilhelm; Michael Huber; Carolin N Zorn
Journal:  Cell Commun Signal       Date:  2016-05-20       Impact factor: 5.712

6.  Endotoxin tolerance in mast cells, its consequences for IgE-mediated signalling, and the effects of BCL3 deficiency.

Authors:  Magdalena Poplutz; Maryna Levikova; Juliane Lüscher-Firzlaff; Marina Lesina; Hana Algül; Bernhard Lüscher; Michael Huber
Journal:  Sci Rep       Date:  2017-07-03       Impact factor: 4.379

Review 7.  Cold shock proteins: from cellular mechanisms to pathophysiology and disease.

Authors:  Jonathan A Lindquist; Peter R Mertens
Journal:  Cell Commun Signal       Date:  2018-09-26       Impact factor: 5.712

8.  Protein phosphatase 2A modulates podocyte maturation and glomerular functional integrity in mice.

Authors:  Xiujuan Zhu; Yuhong Ye; Chengxian Xu; Cunji Gao; Yingying Zhang; Jing Zhou; Weiqiang Lin; Jianhua Mao
Journal:  Cell Commun Signal       Date:  2019-08-06       Impact factor: 5.712

Review 9.  Y-Box Binding Proteins in mRNP Assembly, Translation, and Stability Control.

Authors:  Daria Mordovkina; Dmitry N Lyabin; Egor A Smolin; Ekaterina M Sogorina; Lev P Ovchinnikov; Irina Eliseeva
Journal:  Biomolecules       Date:  2020-04-11

10.  Altered monocytic phenotypes are linked with systemic inflammation and may be linked to mortality in dialysis patients.

Authors:  Sabine Brandt; Lara Ewert; Florian G Scurt; Charlotte Reichardt; Jonathan A Lindquist; Xenia Gorny; Berend Isermann; Peter R Mertens
Journal:  Sci Rep       Date:  2019-12-13       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.